CABANA: 60 Second Insights

Published: 18 June 2018

  • Views:

    Views Icon 577

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Key opinion leaders discuss their thoughts on the CABANA Trial in a series of 60-second videos. Get their views in under 1 minute!

More from this programme

Part 1

Are further studies needed?

2 sessions
Atul Verma Watch now
Johannes Brachmann Watch now

Part 2

How will CABANA change your practice?

2 sessions
Atul Verma Watch now
Johannes Brachmann Watch now

Part 3

What was the biggest weakness of CABANA?

2 sessions
Atul Verma Watch now
Johannes Brachmann Watch now

Part 4

What was the biggest strength of CABANA?

2 sessions
Atul Verma Watch now
Johannes Brachmann Watch now

Part 5

Why do you think CABANA misses its primary endpoint?

2 sessions
Atul Verma Watch now
Johannes Brachmann Watch now

Part 6

Should we stop catheter ablation after CABANA?

2 sessions
Atul Verma Watch now
Johannes Brachmann Watch now

Part 7

Can you describe CABANA in your own words?

2 sessions
Atul Verma Watch now
Johannes Brachmann Watch now

Faculty Biographies

Atul Verma

Atul Verma

Director of Cardiology

Dr Atul Verma is currently Director of Cardiology at the McGill University Health Centre & McGill University, Montreal, CA. He is head of the Heart Rhythm Programme at Southlake Regional Health Centre and an Associate Professor at the University of Toronto, US. He is also an Associate Scientist with the Li Ka Shing Knowledge Institute.

Specialising in complex arrhythmias like atrial fibrillation and ventricular tachycardia, he has published over 300 peer-reviewed articles including in The New England Journal of Medicine. Dr Verma has co-chaired the Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee and contributed to the HRS/EHRA Consensus Document on Catheter Ablation of Atrial Fibrillation. He currently leads and participates in multiple international clinical trials.

View full profile